ENTA Annual Revenue
$67.64 M
-$11.57 M-14.61%
30 September 2024
Summary:
As of January 23, 2025, ENTA annual revenue is $67.64 million, with the most recent change of -$11.57 million (-14.61%) on September 30, 2024. During the last 3 years, it has fallen by -$29.44 million (-30.33%). ENTA annual revenue is now -67.27% below its all-time high of $206.63 million, reached on September 30, 2018.ENTA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTA Quarterly Revenue
$14.61 M
-$3.36 M-18.72%
30 September 2024
Summary:
As of January 23, 2025, ENTA quarterly revenue is $14.61 million, with the most recent change of -$3.36 million (-18.72%) on September 30, 2024. Over the past year, it has dropped by -$4.33 million (-22.84%). ENTA quarterly revenue is now -81.15% below its all-time high of $77.50 million, reached on December 31, 2014.ENTA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTA TTM Revenue
$67.64 M
-$4.33 M-6.01%
30 September 2024
Summary:
As of January 23, 2025, ENTA TTM revenue is $67.64 million, with the most recent change of -$4.33 million (-6.01%) on September 30, 2024. Over the past year, it has dropped by -$11.57 million (-14.61%). ENTA TTM revenue is now -71.63% below its all-time high of $238.40 million, reached on December 31, 2018.ENTA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.6% | -22.8% | -14.6% |
| 3 y3 years | -30.3% | -38.0% | -30.3% |
| 5 y5 years | -67.0% | -38.0% | -30.3% |
ENTA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.3% | at low | -47.2% | at low | -27.3% | at low |
| 5 y | 5-year | -67.0% | at low | -72.2% | at low | -64.0% | at low |
| alltime | all time | -67.3% | +197.1% | -81.2% | +1871.3% | -71.6% | +9027.5% |
Enanta Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $67.64 M(-14.6%) | $14.61 M(-18.7%) | $67.64 M(-6.0%) |
| June 2024 | - | $17.97 M(+5.4%) | $71.96 M(-1.3%) |
| Mar 2024 | - | $17.05 M(-5.3%) | $72.88 M(-1.0%) |
| Dec 2023 | - | $18.00 M(-4.9%) | $73.62 M(-7.0%) |
| Sept 2023 | $79.20 M(-8.1%) | $18.93 M(+0.2%) | $79.20 M(-1.7%) |
| June 2023 | - | $18.89 M(+6.2%) | $80.59 M(-0.7%) |
| Mar 2023 | - | $17.80 M(-24.5%) | $81.18 M(-1.1%) |
| Dec 2022 | - | $23.59 M(+16.1%) | $82.10 M(-4.7%) |
| Sept 2022 | $86.16 M(-11.2%) | $20.32 M(+4.3%) | $86.16 M(-3.6%) |
| June 2022 | - | $19.48 M(+4.1%) | $89.42 M(-2.3%) |
| Mar 2022 | - | $18.72 M(-32.3%) | $91.56 M(-1.5%) |
| Dec 2021 | - | $27.65 M(+17.3%) | $92.98 M(-4.2%) |
| Sept 2021 | $97.07 M(-20.7%) | $23.57 M(+9.0%) | $97.07 M(-0.1%) |
| June 2021 | - | $21.62 M(+7.4%) | $97.13 M(+3.2%) |
| Mar 2021 | - | $20.13 M(-36.6%) | $94.16 M(-7.4%) |
| Dec 2020 | - | $31.74 M(+34.3%) | $101.65 M(-17.0%) |
| Sept 2020 | $122.47 M(-40.3%) | $23.63 M(+26.7%) | $122.47 M(-18.4%) |
| June 2020 | - | $18.65 M(-32.5%) | $150.16 M(-14.6%) |
| Mar 2020 | - | $27.62 M(-47.5%) | $175.87 M(-6.4%) |
| Dec 2019 | - | $52.57 M(+2.4%) | $187.88 M(-8.4%) |
| Sept 2019 | $205.20 M(-0.7%) | $51.31 M(+15.7%) | $205.20 M(-7.2%) |
| June 2019 | - | $44.37 M(+12.0%) | $221.09 M(-5.5%) |
| Mar 2019 | - | $39.63 M(-43.3%) | $233.98 M(-1.9%) |
| Dec 2018 | - | $69.89 M(+4.0%) | $238.40 M(+15.4%) |
| Sept 2018 | $206.63 M | $67.20 M(+17.4%) | $206.63 M(-4.1%) |
| June 2018 | - | $57.26 M(+30.0%) | $215.35 M(+30.0%) |
| Mar 2018 | - | $44.05 M(+15.6%) | $165.60 M(+26.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | $38.11 M(-49.8%) | $130.51 M(+26.9%) |
| Sept 2017 | $102.81 M(+16.5%) | $75.93 M(+910.9%) | $102.81 M(+158.8%) |
| June 2017 | - | $7.51 M(-16.2%) | $39.73 M(-14.0%) |
| Mar 2017 | - | $8.96 M(-14.0%) | $46.20 M(-8.1%) |
| Dec 2016 | - | $10.42 M(-18.9%) | $50.24 M(-43.1%) |
| Sept 2016 | $88.27 M(-45.1%) | $12.84 M(-8.1%) | $88.27 M(-1.8%) |
| June 2016 | - | $13.98 M(+7.5%) | $89.84 M(+2.7%) |
| Mar 2016 | - | $13.00 M(-73.2%) | $87.46 M(-33.7%) |
| Dec 2015 | - | $48.45 M(+236.1%) | $131.83 M(-18.1%) |
| Sept 2015 | $160.88 M(+237.0%) | $14.42 M(+24.3%) | $160.88 M(+7.9%) |
| June 2015 | - | $11.60 M(-79.8%) | $149.10 M(-17.0%) |
| Mar 2015 | - | $57.37 M(-26.0%) | $179.55 M(+44.4%) |
| Dec 2014 | - | $77.50 M(+2838.9%) | $124.35 M(+160.5%) |
| Sept 2014 | $47.74 M(+48.9%) | $2.64 M(-93.7%) | $47.74 M(+2.8%) |
| June 2014 | - | $42.05 M(+1846.8%) | $46.45 M(+667.7%) |
| Mar 2014 | - | $2.16 M(+141.9%) | $6.05 M(+19.0%) |
| Dec 2013 | - | $893.00 K(-33.8%) | $5.09 M(-84.1%) |
| Sept 2013 | $32.05 M(-23.1%) | $1.35 M(-18.2%) | $32.05 M(-1.6%) |
| June 2013 | - | $1.65 M(+37.9%) | $32.56 M(-2.7%) |
| Mar 2013 | - | $1.20 M(-95.7%) | $33.45 M(-51.4%) |
| Dec 2012 | - | $27.86 M(+1399.4%) | $68.82 M(+65.0%) |
| Sept 2012 | $41.71 M(-0.4%) | $1.86 M(-26.9%) | $41.71 M(+4.7%) |
| June 2012 | - | $2.54 M(-93.0%) | $39.85 M(+6.8%) |
| Mar 2012 | - | $36.56 M(+4834.5%) | $37.31 M(+4934.5%) |
| Dec 2011 | - | $741.00 K | $741.00 K |
| Sept 2011 | $41.88 M(+84.0%) | - | - |
| Sept 2010 | $22.76 M | - | - |
FAQ
- What is Enanta Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual revenue year-on-year change?
- What is Enanta Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly revenue year-on-year change?
- What is Enanta Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM revenue year-on-year change?
What is Enanta Pharmaceuticals annual revenue?
The current annual revenue of ENTA is $67.64 M
What is the all time high annual revenue for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual revenue is $206.63 M
What is Enanta Pharmaceuticals annual revenue year-on-year change?
Over the past year, ENTA annual revenue has changed by -$11.57 M (-14.61%)
What is Enanta Pharmaceuticals quarterly revenue?
The current quarterly revenue of ENTA is $14.61 M
What is the all time high quarterly revenue for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly revenue is $77.50 M
What is Enanta Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, ENTA quarterly revenue has changed by -$4.33 M (-22.84%)
What is Enanta Pharmaceuticals TTM revenue?
The current TTM revenue of ENTA is $67.64 M
What is the all time high TTM revenue for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM revenue is $238.40 M
What is Enanta Pharmaceuticals TTM revenue year-on-year change?
Over the past year, ENTA TTM revenue has changed by -$11.57 M (-14.61%)